Academic literature on the topic 'HYPERTENSIVE DRUGS'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'HYPERTENSIVE DRUGS.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "HYPERTENSIVE DRUGS"

1

Wilson, J., M. A. Orchard, A. A. Spencer, J. A. Davies, and C. R. M. Prentice. "Anti-Hypertensive Drugs Non-Specifically Reduce “Spontaneous” Activation of Blood Platelets." Thrombosis and Haemostasis 62, no. 02 (1989): 776–80. http://dx.doi.org/10.1055/s-0038-1646901.

Full text
Abstract:
SummaryAbnormal activation of blood platelets may be a contributory factor in the accelerated vascular disease which occurs in hypertension. We investigated the effects of lowering blood pressure in 12 patients with mild hypertension on several aspects of platelet function, initially in a placebo-controlled, double-blind, crossover study with nisoldipine, and subsequently in the same patients comparing nisoldipine with the patients’ usual anti-hypertensive therapy. Values were compared with those from an age, sex-matched control population. Seven hypertensive patients with renal failure were a
APA, Harvard, Vancouver, ISO, and other styles
2

O'Collins, Victoria E., Geoffrey A. Donnan, Malcolm R. Macleod, and David W. Howells. "Hypertension and Experimental Stroke Therapies." Journal of Cerebral Blood Flow & Metabolism 33, no. 8 (2013): 1141–47. http://dx.doi.org/10.1038/jcbfm.2013.88.

Full text
Abstract:
Hypertension is an established target for long-term stroke prevention but procedures for management of hypertension in acute stroke are less certain. Here, we analyze basic science data to examine the impact of hypertension on candidate stroke therapies and of anti-hypertensive treatments on stroke outcome. Methods: Data were pooled from 3,288 acute ischemic stroke experiments (47,899 animals) testing the effect of therapies on infarct size (published 1978-2010). Data were combined using meta-analysis and meta-regression, partitioned on the basis of hypertension, stroke model, and therapy. Res
APA, Harvard, Vancouver, ISO, and other styles
3

Wang, Jiwu. "History of Development, Classification, Mechanism of Action and Rational Application of Major Anti-Hypertensive Drugs." International Journal of Public Health and Medical Research 1, no. 2 (2024): 44–52. http://dx.doi.org/10.62051/ijphmr.v1n2.07.

Full text
Abstract:
With the rise of the aging population, the number of people with high blood pressure is increasing. Hypertension can cause cerebral hemorrhage, cerebral infarction, heart failure, coronary atherosclerotic heart disease and renal failure. One of the most common treatments for hypertension is drug therapy. Common anti-hypertensive drugs include angioplasty-converting enzyme inhibitors, calcium channel blockers, adrenergic receptor antagonists, diuretics, central anti-hypertensive drugs and vasodilation. The types of drugs used vary depending on the individual's condition. This article reviews th
APA, Harvard, Vancouver, ISO, and other styles
4

Bhandary, Apeksha, and Prasan R. Bhandari. "Drug usage pattern of anti-hypertensive drugs in elderly diabetic, hypertensive in-patients with or without impaired renal function in a tertiary care hospital." International Journal of Basic & Clinical Pharmacology 7, no. 4 (2018): 696. http://dx.doi.org/10.18203/2319-2003.ijbcp20181172.

Full text
Abstract:
Background: Hypertension (HTN) and Diabetes mellitus (DM) are the leading contributors to the cardiovascular mortality and morbidity. Drug utilisation studies (DUS) are potential tools in the evaluation in health care systems. Objectives was to analyse the drug usage pattern of anti-hypertensives in elderly hypertensive diabetic in-patients in a tertiary hospital. To analyse drug usage pattern of anti-hypertensives in elderly hypertensive, diabetic in-patients with renal impairment in a tertiary hospital.Methods: The study population consisted of 165 hypertensive diabetic in-patients at Shri D
APA, Harvard, Vancouver, ISO, and other styles
5

Risna, Amalia, Jauhar Latifah, Linda Permata Sari, Ronalisa Ronalisa, Henny Maryani, and Difa Intannia. "PROFIL PERESEPAN PENGGUNAAN ANTIHIPERTENSI PADA PASIEN RAWAT JALAN DI PUSKESMAS SUNGAI ULIN PERIODE OKTOBER 2020." Jurnal Insan Farmasi Indonesia 5, no. 1 (2022): 8–15. http://dx.doi.org/10.36387/jifi.v5i1.913.

Full text
Abstract:
Hypertension is a disease that often causes death because many people do not realize it. People have hypertension if the blood pressure above 140/90 mmHg after regular checking. In Sungai Ulin Public health center, hypertension is the second-highest disease. The study aimed to determine the characteristics of hypertensive patients and the profile of prescribing the use of anti-hypertensive drugs in outpatients in the period October 2020 at Sungai Ulin Public health center. This research is an observational descriptive study using retrospective data with the inclusion criteria. A population of
APA, Harvard, Vancouver, ISO, and other styles
6

Aryunadi, Yudha Fahmi, Ahmad Azrul Zuniarto, Fitri Zakiah, and Anggun Marselina Hermawan. "Effectiveness and Monitoring of Side Effects of Hypertension Drugs in the Elderly in Kalijaga Village." Saudi Journal of Medical and Pharmaceutical Sciences 10, no. 11 (2024): 855–62. https://doi.org/10.36348/sjmps.2024.v10i11.011.

Full text
Abstract:
Hypertension is the disease with the highest prevalence in Indonesia. Prevalence of hypertension in the elderly aged 55-75 years and above, which is 62.63% of the overall percentage of people with hypertension. However, many elderly people are not aware and responsive to the treatment of hypertension. The use of anti-hypertensive drugs is often not taken with good procedures. The purpose of this study was to determine the effectiveness and side effects of anti-hypertensive drugs consumed by the elderly in Kalijaga. Sampling using purposive sampling technique with a sample of 30 respondents wit
APA, Harvard, Vancouver, ISO, and other styles
7

Jaryal, Ajay, Bhupender Kumar, Nripen Gaur, Kapil Sharma, Sanjay Vikrant, and Nitin Kumar. "Prevalence of hypertension-mediated target organ damage in hypertensive patients in an outpatient setting – An observational study." International Journal of Noncommunicable Diseases 10, no. 1 (2025): 12–16. https://doi.org/10.4103/jncd.jncd_51_24.

Full text
Abstract:
ABSTRACT Aim: We aimed to study the clinical profile of hypertensive patients in an outpatient setting and to assess the burden and pattern of hypertension-mediated target organ damage (HMOD). Materials and Methods: A prospective observational study evaluated the clinical profile of hypertensive patients who attended a general internal medicine outpatient clinic over 1 year from April 2022 to March 2023. Results: A total of 454 patients (64.5% – preexisting hypertension, 35.5% – newly diagnosed) were found hypertensive during outpatient visits during the study period. About 22.7% had symptoms
APA, Harvard, Vancouver, ISO, and other styles
8

Cífková, Renata. "Antiplatelet and Lipid-lowering Drugs in Hypertension." European Cardiology Review 9, no. 1 (2014): 16. http://dx.doi.org/10.15420/ecr.2014.9.1.16.

Full text
Abstract:
Antiplatelet therapy, and low-dose acetylsalicylic acid (ASA) in particular, is recommended in hypertensive patients with previous cardiovascular events and is considered in hypertensive patients with reduced renal function or a high cardiovascular (CV) risk, provided blood pressure is well-controlled. Acetylsalicylic acid is not recommended in low-to-moderate risk hypertensive patients in whom absolute benefit and harm are equivalent. Further trials evaluating antithrombotic therapy including newer agents in hypertension are needed. Women at high and moderate risk of pre-eclampsia are advised
APA, Harvard, Vancouver, ISO, and other styles
9

Ullah, Mohammad, Suman Kumar Saha, Md Toufiqur Rahman, Md Abdul Karim, and Rashid Ahmed. "Nonadherence to Drugs among the Hypertensive Patients in Outpatient Department of a Secondary Hospital of Bangladesh." Cardiovascular Journal 11, no. 2 (2019): 105–13. http://dx.doi.org/10.3329/cardio.v11i2.40409.

Full text
Abstract:
Background: One fifth Bangladeshi adults are hypertensive. Forty percent of them know that they are hypertensive. 53% to 75% hypertensive people have got uncontrolled hypertension. One of the most important causes of uncontrolled hypertension is nonadherence to drugs. We tried to find the causes of non adherence of drugs among the patients with HTN in a secondary care hospital of Bangladesh.
 Methods: The study was conducted from March 2018 to June 2018. Total 144 patients with HTN were included in the study. Taking drugs in less than 80% of the days of previous six months was defined as
APA, Harvard, Vancouver, ISO, and other styles
10

Rajak, Devraj, Deepali Sahu, Anushree Jain, et al. "Review on Toxicity of Antihypertensive Drugs." Asian Journal of Dental and Health Sciences 2, no. 4 (2022): 64–68. http://dx.doi.org/10.22270/ajdhs.v2i4.28.

Full text
Abstract:
Adverse drug reactions are common and pose a serious health problem, limiting treatment options, causing compliance issues, and even leading to therapy discontinuation. Hypertension is a chronic disease that is regarded as a major risk factor for cardiovascular disease. To achieve a target blood pressure in an individual patient, a wide range of anti-hypertensive agents are available as single or combination therapy, whereas combination therapy increases the risk of developing Adverse Drug Reaction. Hypertensive patients frequently have coexisting disease conditions such as hyperlipidemia, imp
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "HYPERTENSIVE DRUGS"

1

Nievelstein, Hubert Nicolas Maria Willem. "Hemodynamic effects of antihypertensive drugs in conscious spontaneously hypertensive rats." Maastricht : Maastricht : Rijksuniversiteit Limburg ; University Library, Maastricht University [Host], 1987. http://arno.unimaas.nl/show.cgi?fid=5367.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Beaubien, Eliot R. "Non-steroidal anti-inflammatory drugs and the risk of end stage renal disease in hypertensive individuals." Thesis, McGill University, 2004. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=81593.

Full text
Abstract:
Objective. To examine the association between non-steroidal anti-inflammatory drug (NSAID) use and end stage renal disease (ESRD) among hypertensive subjects.<br>Study design. We conducted a nested case-control study within a cohort of 77,887 hypertensive adult subjects within the province of Saskatchewan, Canada.<br>Outcome. The primary outcome was ESRD, defined by chronic dialysis or renal transplantation.<br>Exposure. NSAID exposure was determined using prescription records, for various time windows up to 10 years preceding the onset of end stage renal disease.<br>Statistical analysi
APA, Harvard, Vancouver, ISO, and other styles
3

Komulainen, S. (Silja). "Effect of antihypertensive drugs on blood pressure during exposure to cold:experimental study in normotensive and hypertensive subjects." Doctoral thesis, University of Oulu, 2007. http://urn.fi/urn:isbn:9789514286131.

Full text
Abstract:
Abstract The aim of the present study was to describe the effects of different types of cold exposures on blood pressure (BP) and heart rate (HR) and to test how these cold-induced effects are modulated by antihypertensive drugs representing different kind of mechanisms of action. The tested drugs represented the following antihypertensive drug subgroups: metoprolol from beta-blocking agents, carvedilol from alfa- and beta-blocking agents, lisinopril from angiotensin converting enzyme inhibitors, eprosartan from angiotensin II antagonists, amlodipine from calcium channel blockers and hydrochlo
APA, Harvard, Vancouver, ISO, and other styles
4

Filho, Gilberto Senechal de Goffredo. "Incapacidade temporária para atividades habituais: relação com a pressão arterial e o uso de terapia farmacológica antihipertensiva no Estudo Pró-Saúde." Universidade do Estado do Rio de Janeiro, 2008. http://www.bdtd.uerj.br/tde_busca/arquivo.php?codArquivo=5021.

Full text
Abstract:
A hipertensão arterial (HA) desempenha papel determinante na ocorrência de eventos clínicos graves, havendo entretanto controvérsia quanto ao seu impacto no cotidiano do portador. A incapacidade temporária para a realização de atividades habituais, definida como uma restrição temporária na capacidade funcional habitual do indivíduo, é um indicador de saúde recomendado pela Organização Mundial da Saúde para uso em estudos populacionais. A partir do objetivo geral de investigar a associação entre hipertensão arterial e incapacidade temporária para atividades habituais, delineamos os seguintes ob
APA, Harvard, Vancouver, ISO, and other styles
5

Forino, Andrew Stephen. "Determining Effects of the PAF-R and Anti-Hypertensive Drugs Mediated Microvesicle Particle Release in Modulating Anti-Tumor Response of Lung Cancer." Wright State University / OhioLINK, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=wright1590691151424173.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Merlo, Juan. "Pharmacoepidemiologic studies on cardiovascular drugs with special reference to the effectiveness and safety of blood pressure lowering drugs /." Lund : Dept. of Community Medicine, Lund University, and the NEPI Foundation, 1998. http://books.google.com/books?id=c_BsAAAAMAAJ.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Moore, Suzanne P. "Adherence to randomised drug regimens of patients enrolled in the Second Australian National Blood Pressure Study : a description of the patterns of adherence and of factors influencing non-adherence /." [St. Lucia, Qld.], 2001. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe16251.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Yates, John. "Haemodynamic effects of vasoactive drugs in experimental portal hypertension." Thesis, Liverpool John Moores University, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.337787.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Yu, Zhen. "Altered drug responses in diabetic and hypertensive-diabetic cardiomyopathy." Thesis, University of British Columbia, 1990. http://hdl.handle.net/2429/29406.

Full text
Abstract:
Diabetes mellitus has been associated with both clinical and experimental cardiac dysfunction. Diabetic cardiomyopathy which is characterized by depressed cardiac contractility is accompanied by a variety of biochemical changes in Ca⁺⁺ metabolism. This cardiomyopathy may occur in the presence of normal coronary arteries and normal blood pressure. However, some studies have shown that hypertension is more prevalent among diabetics and can aggravate the cardiovascular abnormalities associated with diabetes. To understand the mechanisms of diabetic cardiomyopathy and consequences of combined hype
APA, Harvard, Vancouver, ISO, and other styles
10

Greer, I. A. "The effect of anti-hypertensive agents on platelets, prostacylin and thromboxane and observations on prostacyclin and thromboxane in normal and hypertensive pregnancy." Thesis, University of Glasgow, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.380334.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "HYPERTENSIVE DRUGS"

1

Switzerland) International Symposium Clonidine in Hypertension (1984 Geneva. Low dose oral and transdermal therapy of hypertension: International Symposium Clonidine in Hypertension, Geneva, 14th-16th June, 1984. Steinkopff, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

M, Drayer Jan I., Lowenthal David T, and Weber Michael A, eds. Drug therapy in hypertension. Dekker, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

H, Messerli Franz, and Opie Lionel H, eds. Combination drug therapy for hypertension. Author's Pub. House, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mann, Samuel J. Hypertension and you: Old drugs, new drugs, and the right drugs for your high blood pressure. Rowman & Littlefield Publishers, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

van, Zwieten P. A., and Greenlee William J, eds. Antihypertensive drugs. Harwood Academic Publishers, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

1947-, Martin John E., and Dubbert Patricia M, eds. Non-drug treatments for essential hypertension. Pergamon Press, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bönner, Gerd. Prostacyclin and hypertension. Springer-Verlag, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Parsont, Wolfson Rita, ed. How to control high blood pressure without drugs. Scribner, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Walter, Flamenbaum, and Punzi Henry A, eds. Hypertension. Futura Pub. Co., 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Richard, Trubo, ed. The H.A.R.T. program: Lower your blood pressure without drugs. HarperCollins Publishers, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "HYPERTENSIVE DRUGS"

1

Iturrioz, Xavier, Annabelle Reaux, Le Goazigo, and Catherine Llorens-Cortes. "Aminopeptidase Inhibitors as Anti-Hypertensive Drugs." In Aminopeptidases in Biology and Disease. Springer US, 2004. http://dx.doi.org/10.1007/978-1-4419-8869-0_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kuriyama, Yoshihiro, Tohru Sawada, and Teruo Omae. "Antihypertensive Drugs and Cerebral Circulation." In How Should Elderly Hypertensive Patients Be Treated? Springer Japan, 1989. http://dx.doi.org/10.1007/978-4-431-68340-7_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Cockcroft, John R., and David J. Webb. "Phase I Trials on Anti-hypertensive Drugs." In Early Phase Drug Evaluation in Man. Macmillan Education UK, 1990. http://dx.doi.org/10.1007/978-1-349-10705-6_24.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Voicu, Victor, and Maria Dorobantu. "New Drugs for the Hypertensive Failing Heart." In Updates in Hypertension and Cardiovascular Protection. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-93320-7_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Nakamaru, Mitsuaki, Toshio Ogihara, Hiroshi Mikami, et al. "Complications and the Choice of Antihypertensive Drugs in the Elderly." In How Should Elderly Hypertensive Patients Be Treated? Springer Japan, 1989. http://dx.doi.org/10.1007/978-4-431-68340-7_21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sarros, G., H. Nastou, A. Nastos, V. Sarrou, N. Fotopoulos, and J. Anastassopoulou. "Molecular Design and FT-IR Spectra of Hypertensive Drugs." In Spectroscopy of Biological Molecules. Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-011-0371-8_261.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kirpizidis, H. G. "Quality of Life, Drugs and Diet in Hypertensive Patients." In Handbook of Disease Burdens and Quality of Life Measures. Springer New York, 2010. http://dx.doi.org/10.1007/978-0-387-78665-0_173.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Agrawal, S. S. "Development of Transdermal and Transbuccal Drug Delivery Systems for Cardioactive Drugs with Special Reference to Anti- Hypertensive Agents." In Atherosclerosis, Hypertension and Diabetes. Springer US, 2003. http://dx.doi.org/10.1007/978-1-4419-9232-1_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Escher, Emanuel. "Angiotensin II Antagonists with Prolonged Duration of Action Possible Anti-Hypertensive Drugs." In Molecular Biology of Brain and Endocrine Peptidergic Systems. Springer US, 1988. http://dx.doi.org/10.1007/978-1-4684-8801-2_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Bernstein, Donald P. "How Should You Manage Anti-Hypertensive Drugs in Morbidly Obese Surgical Patients?" In Controversies in the Anesthetic Management of the Obese Surgical Patient. Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-2634-6_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "HYPERTENSIVE DRUGS"

1

Biswas, Md Emran, M. D. Fazle Hasan Mihad, Farhad Hossain Sojib, et al. "A Bioinformatics Approach to Uncover Hub Genes and Potential Drug Targets of Stroke, Heart-Disease, Hyperglycemia, and Hypertension." In 2024 27th International Conference on Computer and Information Technology (ICCIT). IEEE, 2024. https://doi.org/10.1109/iccit64611.2024.11022540.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Wilson, J., M. A. Orchard, A. A. Spencer, J. A. Davies, and C. R. M. Prentice. "TREATMENT OF RAISED BLOOD PRESSURE WITH NISOLDIPINE REDUCES "SPONTANEOUS" PLATELET AGGREGATION IN WHOLE BLOOD." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644260.

Full text
Abstract:
Hypertensive patients are at risk of premature vascular disease, and abnormalplatelet function in hypertensive subjects may contribute to vascular damage. Ina placebo controlled, double blind, cross over study, we have investigated theeffect of treatment of moderate hypertension with nisoldipine (a 1,4, dihydropyridine calcium antagonist) on several aspects of platelet function. In 12 hypertensive subjects, venous blood samples were taken for platelet count, PCV, βTG, PF4, and aggregation to standard doses of ADP and adrenaline in whole blood. Platelet aggregation in whole blood which occurred
APA, Harvard, Vancouver, ISO, and other styles
3

Martins, A. V. V., J. G. A. L. Junior, L. A. Bortolotto, G. Lorenzi-Filho, and L. F. Drager. "Insomnia is Common in Patients with Hypertension and Associated with Higher Need of Anti-hypertensive Drugs." In XIX Congresso Brasileiro do Sono. Thieme Revinter Publicações Ltda., 2023. http://dx.doi.org/10.1055/s-0043-1770250.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Suryantara, A. A., I. Suyasa, Ni Kamaryati, and Ida Diyu. "Determinant Factors Affecting Adherence of Hypertensive Patients to Taking Antihypertensive Drugs." In The Bali Biennial International Conference on Health Sciences. SCITEPRESS - Science and Technology Publications, 2022. http://dx.doi.org/10.5220/0011940700003576.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Yalcin, Huseyin C., Mohamed A. Elrayess, Hadeel T. Al-Jighefee, Mahmoud Khatib A. A. Al-Ruweidi, Shamma Almuraikhy, and Hadi M. Yassine. "Soluble ACE2 and Angiotensin II levels Modulated in Hypertensive COVID-19 Patients treated with different Antihypertension Drugs." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2021. http://dx.doi.org/10.29117/quarfe.2021.0085.

Full text
Abstract:
Hypertension is a major risk factor and common comorbidity among severe Coronavirus Disease 2019 (COVID-19) patients. Prominent antihypertensive drugs, such as angiotensin-converting-enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) can modulate the expression of angiotensin-converting enzyme 2 (ACE2) and may influence COVID-19 prognosis. Other classes of antihypertensive drugs, such as beta-blockers (BB) and calcium channel blockers (CCB) are associated with reduced mortality. Still, their effect on the circulating levels of ACE2 and angiotensin II, as well as the severity of C
APA, Harvard, Vancouver, ISO, and other styles
6

Prihayati, Apriliya, and Pujiyanto Pujiyanto. "Drug Utilization Pattern and Cost Estimates of Anti-Hypertensive Drugs in Pharmacies under the National Health Insurance Program." In The 6th International Conference on Public Health 2019. Masters Program in Public Health, Graduate School, Universitas Sebelas Maret, 2019. http://dx.doi.org/10.26911/the6thicph-fp.04.06.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Prihayati, Apriliya, and Pujiyanto Pujiyanto. "Drug Utilization Pattern and Cost Estimates of Anti-Hypertensive Drugs in Pharmacies Under the National Health Insurance Program." In The 6th International Conference on Public Health 2019. Masters Program in Public Health, Graduate School, Universitas Sebelas Maret, 2019. http://dx.doi.org/10.26911/the6thicph.04.60.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Miloradović, Vladimir, and Neda Ćićarić. "Approaches in the Treatment of Uncontrolled Hypertension." In 7th International Congress of Cardionephrology KARNEF 2025. Punta Niš, 2025. https://doi.org/10.46793/karnef25.332m.

Full text
Abstract:
Despite the availability of antihypertensive drugs, many patients worldwide have uncontrolled hypertension (1,2). In this regard, the term „resistant hypertension“ was introduced, with a prevalence of 10%-20% in hypertensive patients (3). According to the current guidelines of the European Association of Cardiology, hypertension is defined as resistant when the treatment strategy, which includes appropriate lifestyle measures and treatment with maximum or maximally tolerated doses of diuretics (thiazides and thiazide-like diuretics), blockers of the renin-angiotension-aldosterone system (RAAS)
APA, Harvard, Vancouver, ISO, and other styles
9

Rajendran, Rasvini, and Zaitul Marlizawati Zainuddin. "The Determining Factors in Prescribing Anti-Hypertensive Drugs to First-Ever Ischemic Stroke Patients." In 2016 International Conference on Industrial Engineering, Management Science and Application (ICIMSA). IEEE, 2016. http://dx.doi.org/10.1109/icimsa.2016.7504041.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Daudt, Pedro Eugênio Deboni, Alexandre Grunfeld Starling Jardim, and Felipe Ibiapina dos Reis. "Arterial hypertension and cerebrovascular accidents. epidemiological profile of patients attended between 2013 and 2019 in Joinville, Santa Catarina, Brazil." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.344.

Full text
Abstract:
Introduction: Cerebrovascular accident (CVA) is the second cause of death in the world, and arterial hypertension (AH) is the main risk factor. Objetives: To evaluate the prevalence of AH and the epidemiological profile of patients who suffered CVA, first and recurrent events, registered at JOINVASC, between 2013 and 2019. Methodology: An observational, descriptive, retrospective study, analyzing demographic data and risk factors, in patients that suffered CVA, first or recurrent event, was done. Results: In the study period, 6057 CVA events were registered, 4402(72.6%) patients were classifie
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "HYPERTENSIVE DRUGS"

1

Zhang, Yun. Anti-hypertensive drugs for hyperuricemia: a systematic review and network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.10.0059.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Xin, Yuning, Hongyu Li, Gungyu Cheng, et al. Evaluation of the Effectiveness and Safety of Acupuncture in the Treatment of Cervicogenic Hypertension A Protocol for Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.12.0036.

Full text
Abstract:
Review question / Objective: The purpose of this study is to explore the efficacy and safety of acupuncture in the treatment of patients with cervicogenic hypertension,Through scientific verification, it provides clinicians with application reference and provides more choices for patients to solve pain. Patients included should have a clear diagnosis of cervicogenic hypertension(In the absence of antihypertensive drugs, blood pressure was measured 3 times a day, systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg; or a clear history of hypertension and Diagnosis of cer
APA, Harvard, Vancouver, ISO, and other styles
3

Fillipin, Federico, Pamela Seron, and Ruvistay Gutierrez-Arias. Effectiveness of antihypertensive drugs to prevent cognitive decline, mild cognitive impairment, and dementia. An overview of systematic reviews. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.12.0057.

Full text
Abstract:
Review question / Objective: To determine effectiveness of antihypertensive drugs to prevent different dementia subtypes such as Alzheimer’s disease and vascular dementia. Condition being studied: Dementia is a global health burden, with the number of affected individuals increasing. A recent meta-analysis reported that the prevalence of all-type dementia was 697 per 10,000 people and the prevalence of Alzheimer’s disease was 324 per 10,000 people. The SHEP and SYST-EUR were the two first randomized controlled trials to show that hypertension treatment reduces dementia risk.
APA, Harvard, Vancouver, ISO, and other styles
4

Li, YueXin, YangXiao Chen, Lin Fu, et al. A Bayesian Network Meta-analysis on the Efficacy and Safety of Novel Targeted Drugs for Type Ⅰ Pulmonary Hypertension. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.12.0023.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Zhao, Jing, Yuanyuan Zeng, Jieqiong Weng, et al. Evening dosing versus morning regimen drug therapy for hypertension: a meta-analysis of randomized controlled trial. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.8.0005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Treadwell, Jonathan R., James T. Reston, Benjamin Rouse, Joann Fontanarosa, Neha Patel, and Nikhil K. Mull. Automated-Entry Patient-Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes. Agency for Healthcare Research and Quality (AHRQ), 2021. http://dx.doi.org/10.23970/ahrqepctb38.

Full text
Abstract:
Background. Automated-entry consumer devices that collect and transmit patient-generated health data (PGHD) are being evaluated as potential tools to aid in the management of chronic diseases. The need exists to evaluate the evidence regarding consumer PGHD technologies, particularly for devices that have not gone through Food and Drug Administration evaluation. Purpose. To summarize the research related to automated-entry consumer health technologies that provide PGHD for the prevention or management of 11 chronic diseases. Methods. The project scope was determined through discussions with Ke
APA, Harvard, Vancouver, ISO, and other styles
7

Lifestyle changes may be more important than drugs for mild hypertension. National Institute for Health Research, 2019. http://dx.doi.org/10.3310/signal-000713.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Introducing magnesium sulphate for the management of pregnancy induced hypertension. Population Council, 2005. http://dx.doi.org/10.31899/rh16.1012.

Full text
Abstract:
Global studies have demonstrated that using magnesium sulphate (MgSO4) to manage hypertensive disease in pregnancy reduces morbidity and mortality due to severe pre-eclampsia/eclampsia, one of the five direct causes of maternal death. Many countries have been slow to introduce MgSO4 to the detriment of women’s health. There are also critical gaps in health-care provider knowledge, skills, and practice in management of eclampsia. Although the use of MgSO4 was introduced successfully to the Maternity Unit at Kenyatta National Hospital, Nairobi, in 2001, there has been no systematic introduction
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!